Helén Fält elected Member of the Board of the BEAM Alliance
February, 2024
The CEO of QureTech Bio, Helén Fält, has been elected Member of the Board at the BEAM Alliance, where she represents the Swedish and Nordic countries.
Launched in June 2015, the BEAM Alliance (Biotech companies from Europe innovating in Anti-Microbial resistance research) represents over 70 small and medium-sized European companies involved in developing innovative products and kits to tackle antimicrobial resistance (AMR).
Helén Fält, CEO of QureTech BIO, is now a Board Member of the BEAM Alliance.
“It’s an honor to be part of the board, the BEAM Alliance is a pivotal force in innovating against antimicrobial resistance (AMR)” states Helén Fält and continues:
”I’ll be monitoring advancements in AMR specifically for the Nordics, and exchanging information about what’s happening primarily in Europe and globally. We’re committed to informing EU policymakers about antibiotic resistance and the fragile state of clinical product development”.
Notably, Helén Fält is also a chairperson of Sweden BIO’s expert network of Pandemic Preparedness.
Read more about the BEAM Alliance here.